CleteAKushidaMD

Neurology • Stanford, CA

Sleep Medicine

Professor, Psychiatry & Behavioral Science, Stanford University Medical Center

Join to view full profile

Dr. Kushida is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kushida's full profile

Already have an account?

Office
300 Pasteur Dr
Ste 3301
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 650-721-3465

Education & Training

University of California (San Diego) Medical CenterResidency, Neurology, 1991 - 1994
University of HawaiiInternship, Internal Medicine, 1990 - 1991
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 1992 - 2026
HI State Medical License 1990 - 1992

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Apnea Positive Pressure Long-Term Efficacy Study Start of enrollment: 2002 Sep 01
Completed
Phase 3
Positive Pressure Treatment of Obstructive Sleep Apnea Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Comparative Outcomes Management With Electronic Data Technology (COMET) Study Start of enrollment: 2011 Dec 01
Completed
Not Applicable
Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Objective Evaluation of Depression Using Sleep EEG Start of enrollment: 2017 May 01
Completed
Not Applicable
Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea Severity Start of enrollment: 2021 May 01
Withdrawn
Not Applicable
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease Start of enrollment: 2020 Oct 21
Active, not recruiting
Not Applicable
Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH Start of enrollment: 2022 Dec 28
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea.
Clete A Kushida, Gary K Zammit, Jocelyn Y Cheng, Dinesh Kumar, Margaret Moline
Sleep Medicine. 2025-03-01
Response to "Letter to the editor regarding 'Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea' by Ku...
Clete A Kushida, Gary K Zammit, Jocelyn Y Cheng, Dinesh Kumar, Margaret Moline
Sleep Medicine. 2025-02-13
Sleep spindle variation in patients with Parkinson's disease on first nights of sub-optimal deep brain stimulation.
Rig Das, Stephen V Gliske, Dulce Maroni, Miguel Situ-Kcomt, Leslie C West
Clinical Neurophysiology. 2025-02-01

Journal Articles

Impact of Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea During Drug‐Induced Sleep Endoscopy
S Y Liu, R Capasso, V Nekhendzy, C Torre, C A Kushida, Clinical otolaryngology

Lectures

Fetuin-A, Insulin Resistance, and Obstructive Sleep Apnea
Stanford, CA - 6/15/2014
Sex Differences Modulate Relationships among Obesity, Insulin Resistance, and Obstructive Sleep Apnea
Stanford, CA - 6/15/2014

Press Mentions

Poor Sleep in Your 40s Linked to Faster Brain Aging Later in LifeOctober 28th, 2024
Exhibitors Announce Research Findings, Product Updates at SLEEP 2022 Annual MeetingJune 10th, 2022
Preliminary ProgramJune 4th, 2022
Join now to see all